Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bone marrow stem cells are a source of insulin-producing cells

17.03.2003


Study may open way to using bone marrow stem cells as diabetes treatment

In a finding that may open a new avenue to treating diabetes, researchers show that cells from the bone marrow give rise to insulin-producing cells in the pancreas of mice. These morphed cells actually produce the hormone insulin in response to glucose and display other characteristics demonstrating that they truly function as pancreas cells, according to a new study by researchers from NYU School of Medicine.

The study is published in the March 14 issue of the Journal of Clinical Investigation. The researchers caution that the findings cannot be applied to treating diabetics now, but may one day provide a means to produce unlimited quantities of functional insulin-producing cells culled from the bone marrow of diabetes patients. Since patients would produce their own cells for transplantation, it is possible that the cells would not be rejected by their immune system.



"Clearly much work remains to be done," says Mehboob A. Hussain, M.D., Assistant Professor of Medicine and Pharmacology, who led the study. "But I am absolutely excited by the potential applications of our findings," he says. "In our body, there is an additional, easily accessible source of cells that are capable of becoming insulin-producing pancreatic endocrine cells. Transplantation of bone marrow stem cells already is a routine procedure for treating cancer and other diseases, and we could build on that experience."

Dr. Hussain’s study is described as "elegant" in an accompanying editorial by Drs. Vivian Lee and Markus Stoffel, two diabetes researchers from The Rockefeller University, published in the same issue of the journal. Dr. Hussain used a molecular biology technique called "CRE-loxP" that allowed him to identify and isolate bone marrow derived cells and to study them more closely than had previously been possible.

One of the longstanding goals of diabetes research is to find a way to replace the insulin-producing cells in the pancreas that are damaged or destroyed in some forms of diabetes. These cells are called beta cells and they are found in cell groups called islets of Langerhans in the pancreas. In recent years doctors have reported that they successfully transplanted pancreatic islets from cadavers into some severely ill diabetics, most of whom were subsequently freed from daily insulin shots. Insulin regulates blood sugar levels. Immunosuppressive drugs were required to prevent rejection of the transplants.

However, the supply of islets from cadavers is extremely limited, so medical researchers are looking elsewhere. Several research groups have reported that embryonic stem cells and cells found in the pancreas (other than beta cells) could be converted into insulin-producing cells, but until now no one had specifically explored the bone marrow as a source of beta cells. (The bone marrow normally replenishes blood cells and in recent years researchers have shown that stem cells from the marrow can become cells of other organs.)

The CRE-loxP system is a sort of DNA editing technique that molecular biologists widely employ to engineer genes. In the new study, Dr. Hussain used the system to ingeniously create male mice with bone marrow cells that produce a protein called enhanced green fluorescent protein (EGFP) only in the presence of activated insulin genes, which are typically found in pancreatic beta cells. EGFP imparts a green glow to cells, which makes it easy to identify them. He then transplanted the bone marrow from these males into female mice whose bone marrow had been destroyed by radiation.

After four to six weeks, Dr. Hussain detected a small number of the glowing green cells in the pancreatic islets of Langerhans of the female mice. Further analysis showed that these cells came from the bone marrow and functioned as the insulin-producing beta cells. These cells all contained the Y chromosome, which could only have come from the male donor. The cells also secreted insulin in response to glucose, one of the signatures of pancreatic beta cells, and exhibited electrical activity and other properties of beta cells.

Moreover, a second set of experiments showed that these bone marrow derived cells were unlikely to be a result of cells fusing together. Some researchers have suggested that the conversion of stem cells into differentiated tissue is not real, but is due to artifacts of experimental design produced by the fusion of Y chromosome-bearing cells with host cells already present in the tissue. However, in the second set of experiments, Dr. Hussain used the CRE-loxP system to demonstrate that transplanted Y-chromosome bone marrow stem cells are not fusing with pancreas cells in female recipient mice.

Despite the promising results, there are caveats to the study. Only 1.7 to 3 percent of beta cells in the pancreas of the female mice came from transformed bone-marrow stem cells, a small number, and it isn’t known which subpopulation of stem cells in the bone marrow are the actual source of insulin-producing cells. Furthermore, it isn’t known what happens in diabetic mice after bone marrow transplantation. Dr. Hussain has proceeded with similar studies in diabetic mice and with experiments that could help clarify how bone marrow stem cells become beta cells in the pancreas.

"Our study isn’t the final proof," says Dr. Hussain. "We still need to find out how well these converted cells are functioning compared to indigenous beta cells in the pancreas. A lot more work needs to be done. Nevertheless, our study demonstrates the potential for using the bone marrow as a source of insulin-producing cells."


The experiments in the study were performed at NYU School of Medicine and Dr. Hussain’s co-authors are Drs. I. Andreea Ianus, George G. Holz and Neil D. Theise. The study was supported by grants from the National Institutes of Health, the American Diabetes Association, and the Juvenile Diabetes Research Foundation.

Pamela McDonnell | EurekAlert!
Further information:
http://www.med.nyu.edu/

More articles from Health and Medicine:

nachricht Spanish scientists create a 3-D bioprinter to print human skin
24.01.2017 | Carlos III University of Madrid

nachricht Tracking movement of immune cells identifies key first steps in inflammatory arthritis
23.01.2017 | Massachusetts General Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Scientists spin artificial silk from whey protein

X-ray study throws light on key process for production

A Swedish-German team of researchers has cleared up a key process for the artificial production of silk. With the help of the intense X-rays from DESY's...

Im Focus: Quantum optical sensor for the first time tested in space – with a laser system from Berlin

For the first time ever, a cloud of ultra-cold atoms has been successfully created in space on board of a sounding rocket. The MAIUS mission demonstrates that quantum optical sensors can be operated even in harsh environments like space – a prerequi-site for finding answers to the most challenging questions of fundamental physics and an important innovation driver for everyday applications.

According to Albert Einstein's Equivalence Principle, all bodies are accelerated at the same rate by the Earth's gravity, regardless of their properties. This...

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Breaking the optical bandwidth record of stable pulsed lasers

24.01.2017 | Physics and Astronomy

Choreographing the microRNA-target dance

24.01.2017 | Life Sciences

Spanish scientists create a 3-D bioprinter to print human skin

24.01.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>